Pfizer’s Lyme vaccine shows efficacy
Digest more
The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...
Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than 70% efficacy in a ...
They aren't just "pandemic stocks." ...
As oil prices rise with increasing global uncertainty, this pharmaceutical stock emerges as a possible safe haven for income ...
A federal judge blocked parts of HHS's vaccine policy changes, siding with medical groups against Robert F. Kennedy Jr.'s agenda.
Six years after early vaccine trials, the legacy of COVID-19 shots reflects science, public debate, and how perceptions ...
Pfizer Inc (NYSE:PFE) develops medicines and vaccines across multiple therapeutic areas, contributing to the S&P 500 ...
Pfizer's Chief Talent Officer explains how the "pilot in command" framework scaled from nine teams to 700, and why Workday made it real.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results